TickerGuard
Buy Day today: Neutral (51) Mixed market breadth · no major macro event
ABT

Abbott Laboratories

Healthcare · Medical Devices

102.60$ +0.4% vs. previous close Closing price · As of: Sep 18, 2026

Statements

Income Statement

Abbott Laboratories (ABT) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Revenue" came in at 12,593 million $. Tick rows to compare them in a chart.

Tick rows to compare them in a chart (up to 4)

Income Statement ABT
Line item Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 LTM
10,143 10,241 9,964 10,377 10,635 10,974 10,358 11,142 11,369 11,459 11,164 12,593 46,585
5,109 4,983 4,942 5,072 5,209 5,376 4,914 4,854 5,031 4,922 4,881 5,289 20,123
5,034 5,258 5,022 5,305 5,426 5,598 5,444 6,288 6,338 6,537 6,283 7,304 26,462
661 690 683 697 713 728 703 732 785 735 756 882 3,158
2,680 2,724 2,959 2,936 2,895 2,907 3,061 3,090 3,051 3,129 3,740
3,356 3,394 3,637 3,619 3,608 3,608 3,756 4,236 4,308 4,286 4,441 5,522 18,557
1,678 1,864 1,385 1,686 1,818 1,990 1,688 2,052 2,057 2,251 1,842 1,782 7,932
148 235 117 168 166 152 134 121 44 120 174 299 637
1,671 1,795 1,436 1,607 1,940 2,030 1,778 2,150 2,180 2,358 1,449 1,524 7,511
235 201 211 305 294 -7,199 453 371 536 582 372 596 2,086
1,436 1,594 1,225 1,302 1,646 9,229 1,325 1,779 1,644 1,776 1,077 928 5,425
2,643 2,843 2,358 2,580 2,907 2,989 2,668 3,048 3,092 2,822 2,247 1,782 9,943

LTM = last twelve months (sum of the four most recent quarters).

Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?